Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Summit Therapeutics (SMMT) Times Interest Earned: 2016-2024

Historic Times Interest Earned for Summit Therapeutics (SMMT) over the last 3 years, with Dec 2024 value amounting to -$7,290.

  • Summit Therapeutics' Times Interest Earned was N/A to -$7,290 in Q4 2024 from the same period last year, while for Dec 2024 it was -$20.80, marking a year-over-year change of. This contributed to the annual value of -$26.02 for FY2024, which is 29.75% up from last year.
  • Summit Therapeutics' Times Interest Earned amounted to -$7,290 in Q4 2024, which was down 30,546.39% from -$23.79 recorded in Q3 2024.
  • Over the past 5 years, Summit Therapeutics' Times Interest Earned peaked at -$23.79 during Q3 2024, and registered a low of -$7,290 during Q4 2024.
  • Its 1-year average for Times Interest Earned is -$3,657, with a median of -$3,657 in 2024.
  • Data for Summit Therapeutics' Times Interest Earned shows a maximum YoY declined of 14.78% (in 2020) over the last 5 years.
  • Quarterly analysis of 2 years shows Summit Therapeutics' Times Interest Earned stood at -$116.91 in 2020, then followed by -$7,290 in 2024.
  • Its Times Interest Earned was -$7,290 in Q4 2024, compared to -$23.79 in Q3 2024 and -$116.91 in Q1 2020.